Title |
On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer
|
---|---|
Published in |
Breast Cancer Research and Treatment, February 2007
|
DOI | 10.1007/s10549-007-9516-9 |
Pubmed ID | |
Authors |
Martin Smollich, Martin Götte, George W. Yip, Eng-Siang Yong, Christian Kersting, Jeanett Fischgräbe, Isabel Radke, Ludwig Kiesel, Pia Wülfing |
Abstract |
Endothelin-1 (ET-1) and its receptors, ET(A)R and ET(B)R, are overexpressed in breast carcinomas. However, little is known about the relevance of endothelin-converting enzyme-1 (ECE-1) and ET-1 degrading neprilysin (NEP). In this study, expression of ECE-1 and NEP was determined in 600 breast cancer tissue samples by immunohistochemistry; staining results were correlated with clinicopathological parameters. For ECE-1 expression, we found a significant correlation with VEGF (P < 0.001) and ET(A)R expression (P = 0.048). While patients with ECE-1 overexpressing tumours had more frequent disease recurrence (P = 0.03), NEP overexpression correlated with improved disease-free survival (DFS) (P = 0.023) and less frequent metastasis (P = 0.046). Also, a decrease of NEP expression with malignant progression (G1-G3) was found. ECE-1 inhibition using the selective ECE-1 inhibitor RO 67-7447 in MCF-7 breast cancer cells led to a significantly decreased ET-1 expression and reduced cell invasiveness (54.3% of controls, P = 0.014). Our results indicate that overexpression of ECE-1 is associated with unfavourable outcome, whereas NEP positively influences survival. Thus, expression of ECE-1 and NEP may have prognostic relevance. Due to the anti-invasive effect of the selective ECE-1 inhibitor, targeting ECE-1 may represent an innovative option in future breast cancer therapy. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
China | 1 | 3% |
Unknown | 31 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 9 | 28% |
Student > Bachelor | 5 | 16% |
Student > Postgraduate | 4 | 13% |
Student > Master | 3 | 9% |
Student > Doctoral Student | 2 | 6% |
Other | 6 | 19% |
Unknown | 3 | 9% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 7 | 22% |
Biochemistry, Genetics and Molecular Biology | 6 | 19% |
Medicine and Dentistry | 5 | 16% |
Chemistry | 4 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 9% |
Other | 3 | 9% |
Unknown | 4 | 13% |